Baldness Treatment Market

Baldness Treatment Market: The Next Booming Segment in the World| Pfizer, Nanogen, Alès Groupe, Histogen, Concert Pharmaceuticals

Global baldness treatment market is growing at a substantial CAGR of 6.74% in the forecast period of 2019-2026. The report contains data of the base year 2018 and historic year 2017. This rise in market value can be attributed to the increasing prevalence of hair loss across the world, changing lifestyle such as increased consumption of alcohol and tobacco, rising geriatric population, high level of stress or rising incidences of chronic diseases such as polycystic ovary syndrome (PCOS), cancer and rheumatoid arthritis are some factors driving the market growth.
Market Definition: Global Baldness Treatment Market

Baldness also known as alopecia, is a condition when hairs starts falling excessively from the scalp or elsewhere from the body. The reason for hair loss can be hereditary, hormonal changes, medical conditions or medications. Hereditary hair loss with age is the most common cause of baldness and hair loss is most commonly seen in men than women. Symptoms include sudden loosening of hairs from scalp, circular or patchy bald spots.

According to the Hair loss society, approximately 35 million men and 21 million women are suffering from hair loss worldwide. In men hair loss starts at an early age compared to women. At the age of 35 men losses 40% of their hairs and 70 % hair loss at the age of 80.

Market Drivers

Increasing prevalence of hair loss across the world is driving the market growth
Changing lifestyle such as increased consumption of alcohol and tobacco is accelerating the market growth
Growing emphasis on aesthetic appearances is also boosting the growth of this market
Rising geriatric population around the world is enhancing the market growth
High level of stress or rising incidences of chronic diseases such as polycystic ovary syndrome (PCOS), cancer and rheumatoid arthritis are fueling the market growth

Market Restraints

High cost of available hair transplantation treatment also hampers the market growth Restrictions on approved therapies is restricting the market growth
Side effects/allergic reactions are also acting as a major market restraint

Segmentation: Global Baldness Treatment Market

By Types

Androgenic Alopecia
Alopecia Areata
Alopecia Universalis
Alopecia Totalis
Others

By Mechanism of Action

Potassium Channel Opener
Specific 5 Alpha-Reductase Inhibitor
Aldosterone Antagonist
Others

By Drugs

Finasteride
Minoxidil
Dutasteride
Spironolactone
Others

By Diagnosis

Blood Test
Pull Test
Scalp Biopsy
Light Microscopy

By Treatment

Medication
Laser Therapy
Hair Transplant

By Route of Administration

Oral
Topical

By Distribution Channel

Hospital Pharmacy
Retail Pharmacy
Online Pharmacy

By End-Users

Hospitals
Homecare
Specialty Clinics

By Geography

North America
U.S.
Canada
Mexico
Europe
Germany
Italy
U.K.
France
Spain
Netherlands
Belgium
Switzerland
Turkey
Russia
Rest of Europe
Asia-Pacific
Japan
China
India
South Korea
Australia
Singapore
Malaysia
Thailand
Indonesia
Philippines
Rest of Asia Pacific
South America
Brazil
Rest of South America
Middle East & Africa
South Africa
Rest of Middle East & Africa

Key Developments in the Market

In September 2018, Pfizer Inc received Breakthrough Therapy designation from the U.S FDA for PF-06651600, an oral Janus kinase (JAK3) inhibitor. This drug is currently ongoing in phase ll clinical trial for the treatment of alopecia areata, an autoimmune disease that causes hair loss. This designation enables the company for priority review and will help in early approval of the drug

In January 2018, HCell Inc received the Orphan Drug designation from the U.S FDA for HC017AA, an investigational new drug for the treatment of alopecia areata, an autoimmune disease that causes hair loss. This designation enables the company for 7 years of exclusive U.S. marketing of HC017AA on approval, including tax credits for qualified clinical research costs, and a waiver of the prescription drug user fee act (PDUFA) filing fees

Competitive Analysis:

Global baldness treatment market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of baldness treatment market for Global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Key Market Players:

The key market players in the global baldness treatment market are Pfizer Inc, DAIICHI SANKYO COMPANY, LIMITED, Johnson & Johnson Services, Inc, Cipla Inc, Merck & Co., Inc, Sun Pharmaceutical Industries Ltd, Dr. Reddy’s Laboratories Ltd, Church & Dwight Co., Inc, Vitabiotics Ltd, DR. WOLFF-GRUPPE GMBH, Nanogen, Alès Groupe, Histogen Inc, Concert Pharmaceuticals, Inc, Aclaris Therapeutics, Inc, HCell Inc, GlaxoSmithKline plc among others.

Research Methodology: Global Baldness Treatment Market:

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your enquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Primary Respondents:

Demand Side: Doctors, Surgeons, Medical Consultants, Nurses, Hospital Buyers, Group Purchasing Organizations, Associations, Insurers, Medical Payers, Healthcare Authorities, Universities, Technical Writers, Scientists, Promoters, and Investors among others.

Supply Side: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, and Regulatory Affairs Managers among others.

Reasons to Purchase this Report:

Current and future of global baldness treatment market outlook in the developed and emerging markets.
The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.
Regions/Countries that are expected to witness the fastest growth rates during the forecast period.
The latest developments, market shares, and strategies that are employed by the major market players.

Baldness Treatment Market: The Next Booming Segment in the World| Pfizer, Nanogen, Alès Groupe, Histogen, Concert Pharmaceuticals

Source

Previous Posts

Posted in: